Intratumoral Heterogeneity: Tools to Understand and Exploit Clone Wars in AML
- PMID: 30300577
- DOI: 10.1016/j.ccell.2018.09.004
Intratumoral Heterogeneity: Tools to Understand and Exploit Clone Wars in AML
Abstract
In this issue of Cancer Cell, de Boer et al. refine a set of acute myeloid leukemia (AML)-enriched plasma membrane markers that can be used to identify, prospectively isolate, and longitudinally track leukemic subclones within individual AML patients, correlating immunophenotypic profiles with specific mutational signatures, transcription, functional behavior, and therapeutic outcomes.
Copyright © 2018 Elsevier Inc. All rights reserved.
Comment on
-
Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones.Cancer Cell. 2018 Oct 8;34(4):674-689.e8. doi: 10.1016/j.ccell.2018.08.014. Epub 2018 Sep 20. Cancer Cell. 2018. PMID: 30245083
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
